Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection

Vaccination Directed against the Human Endogenous Retrovirus-K Envelope Protein Inhibits Tumor Growth in a Murine Model System

(2013) Benjamin Kraus et al.   PLoS One

Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts

(2012) Arianna Moiani et al.   JOURNAL OF CLINICAL INVESTIGATION

Vaccination with Cancer- and HIV Infection-Associated Endogenous Retrotransposable Elements Is Safe and Immunogenic

(2012) J. B. Sacha et al.   JOURNAL OF IMMUNOLOGY

Protective Effect of Human Endogenous Retrovirus K dUTPase Variants on Psoriasis Susceptibility

(2012) Olivia Y. Lai et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Immunotherapeutic Potential of Anti-Human Endogenous Retrovirus-K Envelope Protein Antibodies in Targeting Breast Tumors

(2012) Feng Wang-Johanning et al.   JNCI-Journal of the National Cancer Institute

HIV infection and HERV expression: a review

(2012) Antoinette C van der Kuyl   Retrovirology

Exon Level Transcriptomic Profiling of HIV-1-Infected CD4+ T Cells Reveals Virus-Induced Genes and Host Environment Favorable for Viral Replication

(2012) Michaël Imbeault et al.   PLoS Pathogens

Ex vivo characterization and isolation of rare memory B cells with antigen tetramers

(2011) B. Franz et al.   BLOOD

Selective changes of retroelement expression in human prostate cancer

(2011) Wolfgang Goering et al.   CARCINOGENESIS

Characterization of Human Endogenous Retroviral Elements in the Blood of HIV-1-Infected Individuals

(2011) R. Contreras-Galindo et al.   JOURNAL OF VIROLOGY

Strong Human Endogenous Retrovirus-Specific T Cell Responses Are Associated with Control of HIV-1 in Chronic Infection

(2011) D. SenGupta et al.   JOURNAL OF VIROLOGY

Expression of human endogenous retrovirus K is stimulated by ultraviolet radiation in melanoma

(2011) Oliver Schanab et al.   Pigment Cell & Melanoma Research

Human Endogenous Retrovirus K106 (HERV-K106) Was Infectious after the Emergence of Anatomically Modern Humans

(2011) Aashish R. Jha et al.   PLoS One

Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses

(2011) Ravi P Subramanian et al.   Retrovirology

Beneficial and detrimental effects of human endogenous retroviruses

(2009) Reinhard Kurth et al.   INTERNATIONAL JOURNAL OF CANCER

Evidence that Ecotropic Murine Leukemia Virus Contamination in TZM-bl Cells Does Not Affect the Outcome of Neutralizing Antibody Assays with Human Immunodeficiency Virus Type 1

(2009) E. J. Platt et al.   JOURNAL OF VIROLOGY

Reconstitution of the Ancestral Glycoprotein of Human Endogenous Retrovirus K and Modulation of Its Functional Activity by Truncation of the Cytoplasmic Domain

(2009) K. Hanke et al.   JOURNAL OF VIROLOGY

Serological Response to Human Endogenous Retrovirus K in Melanoma Patients Correlates with Survival Probability

(2008) Silvia Hahn et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Human Endogenous Retrovirus K Triggers an Antigen-Specific Immune Response in Breast Cancer Patients

(2008) F. Wang-Johanning et al.   CANCER RESEARCH

Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles

(2008) K. Boller et al.   JOURNAL OF GENERAL VIROLOGY

Identification of Gammaretroviruses Constitutively Released from Cell Lines Used for Human Immunodeficiency Virus Research

(2008) Y. Takeuchi et al.   JOURNAL OF VIROLOGY

Conserved Footprints of APOBEC3G on Hypermutated Human Immunodeficiency Virus Type 1 and Human Endogenous Retrovirus HERV-K(HML2) Sequences

(2008) A. E. Armitage et al.   JOURNAL OF VIROLOGY